Search results
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
Associated Press via Yahoo News· 8 months agoJapan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly...
Exclusive-Eisai expects 1,500 Alzheimer's patients in China launch, sees ‘huge’ growth
Reuters via AOL· 4 months agoJapan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China...
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
Reuters via Yahoo News· 8 months agoTOKYO (Reuters) -Japan's Eisai said on Monday its Alzheimer's treatment developed with Biogen,...
Eisai, Biogen Alzheimer's drug could be available to some next year
Reuters via Yahoo News· 2 years agoJapan's Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the...
Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20
Reuters via AOL· 6 months agoEisai said on Wednesday its Alzheimer's drug Leqembi will launch in Japan on Dec. 20 following its...
Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected
Reuters via AOL· 3 months agoJapanese drugmaker Eisai on Thursday said the distribution of its Alzheimer's drug Leqembi in the...
More Eisai/Biogen Alzheimer's drug approvals seen likely despite safety warning
Reuters via Yahoo News· 11 months agoWith U.S. approval of Eisai's and Biogen's Alzheimer's drug Leqembi secured, Wall Street analysts...
Japan gives priority review status to Alzheimer's drug developed by Eisai, Biogen
Reuters via Yahoo News· 1 year agoIn their Jan. 29 statement, the companies said priority review in Japan is granted to new medicines...
New Alzheimer's drug from Biogen, Eisai gets government approval, but faces long road ahead
Yahoo Finance· 11 months agoA new Alzheimer's drug from Eisai and Biogen (BIIB) is now fully approved by the FDA, opening the...
Biogen (BIIB) Partner Eisai Seeks Nod for Lecanemab in Japan
Zacks via Yahoo Finance· 1 year agoBiogen Inc. BIIB and partner Eisai announced that the latter submitted a marketing authorization...